Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results
November 4, 2015 4:06 PM ESTConference Call Scheduled for Today, November 4, 2015, at 3:45 PM CT (4:45 PM ET)
Revenues of $43.9 million and net loss of $(0.41) per share were in line with preliminary results guidance range Company enrolls first patients in OPTIMIZE study LIBERTY 360° study update provided at VIVA Conference; enrollment exceeds 1,100, including over 600 patients with Rutherford classification stages of 4, 5 and 6 TRUTH study demonstrates that CSIs Orbital Atherectomy System is effective at reducing and modifying calciumST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular... More
